View drug registration information details.
Items | Registration information |
ID | 2027 |
No | 2027 |
Brand Name | ATORIN 40 |
Ingredients | ATORVASTATIN CALCIUM TRIHYDRATE 43.280 MG EQ.TO ATORVASTATIN 40 MG |
Dosage Form | FILM-COATED TABLETS |
Primary Packaging | BLISTERPACK |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 10 TABS/BLIST., 10 BLISTS/BOX |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | HYPERCHOLESTEROLAEMIA, HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA OR COMBINED (MIXED) HYPERLIPIDAEMIA IN PATIENTS WHO HAVE NOT RESPONDED ADEQUATELY TO DIET AND OTHER APPROPRIATE MEASURES |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | OFF-WHITE, CIRCULAR, BICONVEX, FILM COATED TABLETS HAVING SCORELINE ON ONE SIDE AND PLAIN ON OTHER SIDES |
Note | |
License Owner | PALAMY PHARMA CO., LTD |
Manufacturer | MEDLEY PHARMACEUTICALS LTD |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 11 I 5648/23 |
FDD Registration Date | 23-NOV-2023 |
Expiry Date | 22-Nov-2026 |
Back to drug list
|